Abstract − The microbial transformation of anthranilic acid (1) by the marine-mudflat-derived fungus Thielavia sp. produced an antibacterial polycyclic quinazoline alkaloid, thielaviazoline (2). The stereostructure of the metabolite was assigned based on detailed spectroscopic data analyses including comparison of the NMR ( 1 H and 13 C) data with those of reported compound (2). Compound 2 displayed in vitro antimicrobial activity against methicillinresistant and multidrug-resistant Staphylococcus aureus (MRSA and MDRSA), with minimum inhibitory concentrations (MICs) of 6.25 and 12.5 µg/mL, respectively. Compound 2 also showed potent radical-scavenging activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH) with an IC 50 of 11 µM, which was more active than the positive control, L-ascorbic acid (IC 50 , 20.0 µM).
Introduction
Microbial transformation of natural products is a powerful tool for generating active, less toxic derivatives.
1,2
We have been exploring the microbial transformation of bioactive compounds by marine-derived microorganisms, and have found that some marine-derived bacteria and fungi regioselectively oxidize bioactive natural products to new, more bioactive compounds.
3-10
In our continuing studies, we initially screened many growing cultures for their ability to catalyze interesting biotransformation reactions with anthranilic acid (1) as substrate. Anthranilic acid (1) , which is an important starting material to synthesize medicine, flavor, pigment, and dye, 11 was isolated with aromatic polyols from a marine isolate of the fungus Aspergillus sp.
12
A culture of the mudflat-derived fungus Thielavia sp. metabolized and transformed compound 1 to a less polar metabolite. Therefore, this strain was selected for preparativescale fermentation of 1
Experimental
General experimental procedures -Optical rotation was determined on a Perkin Elmer model 341 polarimeter.
UV/visible spectra were measured on a Hitachi U-2001 UV/Vis spectrometer. IR spectra were recorded on a Bruker FT-IR model IFS-88 spectrometer. C (δ 39.5)] as reference standard. LC-MS and MS spectra were obtained on API 2000 (Applied Bio System) and IT-TOF (Shimadzu, Japan) spectrometer, respectively. HPLC was performed on a Young Lin ACME HPLC system using a reversedphase analytical column (Gemini C18, 4.6 × 250 mm, 5 μm) with UV detection. Incubations of microorganisms and biotransformations were performed on an Incubator Shaker JS-FS-2500 (Johnsam Co., Inchon, Korea).
Fungal Isolation − The fungal strain, Thielavia sp. (emb/AJ271583.1), was isolated from the marine mudflat collected at Gomso Bay, Korea, and identified based on 18S rRNA an alyses (SolGent Co., Ltd., Daejeon, Korea), with an identity of 98%. A voucher specimen is deposited at Pukyong National University (code MSac49).
Biotransformation of 1 − A two-stage fermentation protocol 13 was used for preparative scale formation of the metabolite of 1. The SWS medium contained soytone (0.1%), soluble starch (1.0%), and seawater (100%), and it was autoclaved at 121 stage II culture, which was incubated for 24 h more under the same condition before receiving 20 mg of 1 in 0.75 mL of N,N-dimethyl formamide (DMF), and incubation was continued at 29 o C for two weeks in the same manner to that described above. Substrate control consisted of sterile medium and substrate incubated under the same conditions but without microorganism. Also, culture control was composed of fermentation blanks in which the microorganism was grown under identical condition but without the addition of substrate. After two weeks of incubation, each control was harvested and analyzed by TLC. The culture was filtered through cheesecloth, and the filtrate was extracted with EtOAc. The organic layer was dried over anhydrous Na 2 SO 4 , filtered through sintered glass, and vacuum-concentrated to yield a crude extract (90 mg).
Isolation of the Metabolite (2) − The crude extract (90 mg) was subjected to silica gel flash column chromatography. Elution was performed with n-hexane-EtOAc (stepwise, 0 -100% EtOAc) to yield four fractions. Fractions 2 and 4 were separated by medium-pressure liquid chromatography (MPLC) (ODS) using a H 2 OMeOH gradient elution to afford crude 2 and 1, respectively. These were further purified by HPLC (Gemini C18, 4.6 × 250 mm, 5 μm) utilizing a 30 min gradient program of 50% to 100% MeOH in H 2 O to furnish the substrate, 1 (7.0 mg), and the metabolite (2) (12.0 mg), respectively.
Thielaviazoline ( Antibacterial Assay 12 − The in vitro antibacterial activity of the fermentation broth and purified samples were evaluated by a conventional 2-fold serial dilution method using S. aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus as indicator strains. A 5 mL suspension containing 10 5 cells per mL was used as inoculum of the test organism. The MICs were determined after the inoculation for 18 h at 37 o C. Oxacillin was used as a positive control at the concentration of 16 μg/mL.
Result and Discussion
Thielaviazoline (2) was isolated as a colorless amorphous solid, identified as C 22 H 19 N 3 O by HR-EI-MS and + were consistent with the 1,4-dihydro-2,3,4-trisubstituted quinazoline and 2,4-dihyhydro-1,2,3,4-tetrasubstituted quinazoline groups ( Fig. 2 and Fig. S1 in the supplementary material) . The connections and positions of the functional groups in 2 were determined based on HMBC spectral data ( Table  1 ). The HMBC correlations from H-1 to 1-OCH 3 showed the connection (C-1-1-OCH 3 ) between the methoxyl moiety and the condensed quinazoline moiety. The HMBC correlations (H-1→C-3, C-7, and C-9; H-9→C-1, C-7, C-11, C-17, C-19, and C-21; H-17 → C-7, C-9, C-11, C-15, and C-19; and NH-18 → C-16, C-20, and C-24) indicated the presence of a quinazoline bis-anhydrotrimer moiety, which was further supported by the chemical shift of the azaacetal protons at δ 5.23 (1H, s, H-9) and 5.36 (1H, d, J = 4.3 Hz, H-17) 15 (Table 1) . Thus, thielaviazoline (2) was characterized as an N-(9,18-dihydro-1H-10,17-orthobenzeno-17H-quinazolino[3,4-a]quinazolin-1-yl)methyl ether. The structure of 2, including stereochemistry, was supported by comparing the NMR data ( 1 H and 13 C in the CDCl 3 ) with the reported NMR data and X-ray structure for the methanol adduct of a 2-aminobenzaldehyde trimer, which was obtained as a side-product during the synthesis of 2-amino-1,4-benzodiazepin-5-ones. 16 Therefore, the relative configurations at C-1, C-9, and C-17 in 2 were assigned as 1S*, 9R*, and 17S*, respectively (Fig. 1) .
We examined compound 2 for antibacterial activity against Staphylococcus aureus, MRSA, and MDRSA, and for radical scavenging activity against DPPH. Compound 2 displayed moderate antibacterial activity against MRSA and MDRSA, with MICs of 6.25 and 12.5 μg/mL, respectively. Compound 2 also exhibited a potent radical scavenging activity against DPPH, with IC 50 value of 10 μM, and 2 was more active than the positive control, ascorbic acid (IC 50 , 20 μM).
Polycyclic quinazoline alkaloid derivatives such as compound 2 have been reported as synthetic intermediates in the development of tribenzo[b,f,j][1,5,9]triazacycloduodecine (TRI) complexes and tetrabenzo[b,f,j,n][l,5,9,13] tetraazacyclohexadecine (TAAB) complexes containing various metals. These complexes have interesting biological activities, including nuclease and superoxide dismutase activities, and antineoplastic activity. 15 Based on the biological activity of the TRI and TAAB complexes derived from the polycyclic quinazoline alkaloid reported above, compound 2 warrants further study for development of potential chemotherapeutic compounds against cancer and diseases related to nucleases and superoxide dismutase.
